Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wilder

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 12, 2000
Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapyR H Chou, R B Wilder, M Ji, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapyGregory M Chronowski, Richard B Wilder, Susan L Tucker, et al.
Brachytherapy|September 9, 2009
A Contura catheter offers dosimetric advantages over a MammoSite catheter that increase the applicability of accelerated partial breast irradiationRichard B Wilder, Lisa D Curcio, Rajesh K Khanijou, et al.
Journal of the American Academy of Dermatology|March 23, 2025
Tumor-infiltrating lymphocyte scoring improves progression risk prediction in stage II melanoma: A retrospective cohort studyGeorge Adigbli, Benedict Reed, Bhavika Khera, et al.
Brachytherapy|October 11, 2015
Health-related quality-of-life changes due to high-dose-rate brachytherapy, low-dose-rate brachytherapy, or intensity-modulated radiation therapy for prostate cancerTobin J Strom, Alex A Cruz, Nick B Figura, et al.
International Journal of Clinical Oncology|September 7, 2014
Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancerArash O Naghavi, Tobin J Strom, Kevin Nethers, et al.
Brachytherapy|October 27, 2009
Preliminary results with accelerated partial breast irradiation in high-risk breast cancer patientsRichard B Wilder, Lisa D Curcio, Rajesh K Khanijou, et al.
The Breast Journal|November 13, 2010
Preliminary Results in 173 Breast Cancer Patients Treated with Post-Lumpectomy MammoSite Single-Lumen Brachytherapy or Multi-Catheter BrachytherapyRichard B Wilder, Lisa D Curcio, Rajesh K Khanijou, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and IIJeff M Michalski, Kathryn Winter, James A Purdy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2010
Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 statusRichard B Wilder, Lisa D Curcio, Rajesh K Khanijou, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|April 12, 2000
Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapyR H Chou, R B Wilder, M Ji, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapyGregory M Chronowski, Richard B Wilder, Susan L Tucker, et al.
Brachytherapy|September 9, 2009
A Contura catheter offers dosimetric advantages over a MammoSite catheter that increase the applicability of accelerated partial breast irradiationRichard B Wilder, Lisa D Curcio, Rajesh K Khanijou, et al.
Journal of the American Academy of Dermatology|March 23, 2025
Tumor-infiltrating lymphocyte scoring improves progression risk prediction in stage II melanoma: A retrospective cohort studyGeorge Adigbli, Benedict Reed, Bhavika Khera, et al.
Brachytherapy|October 11, 2015
Health-related quality-of-life changes due to high-dose-rate brachytherapy, low-dose-rate brachytherapy, or intensity-modulated radiation therapy for prostate cancerTobin J Strom, Alex A Cruz, Nick B Figura, et al.
International Journal of Clinical Oncology|September 7, 2014
Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancerArash O Naghavi, Tobin J Strom, Kevin Nethers, et al.
Brachytherapy|October 27, 2009
Preliminary results with accelerated partial breast irradiation in high-risk breast cancer patientsRichard B Wilder, Lisa D Curcio, Rajesh K Khanijou, et al.
The Breast Journal|November 13, 2010
Preliminary Results in 173 Breast Cancer Patients Treated with Post-Lumpectomy MammoSite Single-Lumen Brachytherapy or Multi-Catheter BrachytherapyRichard B Wilder, Lisa D Curcio, Rajesh K Khanijou, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and IIJeff M Michalski, Kathryn Winter, James A Purdy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2010
Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 statusRichard B Wilder, Lisa D Curcio, Rajesh K Khanijou, et al.
Pageof 11